Patents by Inventor Hervé Bouchard

Hervé Bouchard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
    Patent number: 7759379
    Abstract: The invention relates to compounds of formula (I): in which R1, R2, L1, X, R3, A, R4, R4?, R4?, R4??, R5, Y and L2 are as herein defined, salts and prodrugs thereof, to their use as protein kinase inhibitors, and to methods of treating diseases comprising adminstration thereof.
    Type: Grant
    Filed: January 26, 2007
    Date of Patent: July 20, 2010
    Assignee: Aventis Pharma S.A.
    Inventors: Hartmut Strobel, Sven Ruf, Dominique Lesuisse, Conception Nemecek, Youssef El-Ahmad, Stefan Guessregen, Anne Lebrun, Kurt Ritter, Didier Benard, Augustin Hittinger, Hervé Bouchard
  • Substituted indazoles, compositions containing the same, and the preparation and use thereof
    Patent number: 7517902
    Abstract: Disclosed are novel substituted indazole compounds, pharmaceutical compositions comprising such compounds, and methods of treatment comprising such compounds.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: April 14, 2009
    Assignee: Aventis Pharma S.A.
    Inventors: Frank Halley, Michel Tabart, Hervé Bouchard, Catherine Souaille, Alain Le Brun, Fabrice Viviani, Laurence Gauzy-Lazo, Pascal Desmazeau, Odile Angouillant-Boniface, Bruno Filoche-Romme
  • Substituted tetrahydro-1H-pyrazolo [3,4-c] pyridines, compositions comprising them, and use
    Patent number: 7109340
    Abstract: Substituted tetrahydro-1H-pyrazolo[3,4-c]pyridines, compositions comprising them and use. The present invention relates in particular to novel substituted tetrahydro-1H-pyrazolo[3,4-c]pyridines having therapeutic activity, which can be used in particular in oncology.
    Type: Grant
    Filed: July 9, 2004
    Date of Patent: September 19, 2006
    Assignee: Aventis Pharma S.A.
    Inventors: Fabienne Thompson, Patrick Mailliet, Teresa Damiano, Marie-Pierre Cherrier, Francois Clerc, Frank Halley, Hervé Bouchard, Laurence Gauzy-Lazo, Bernard Baudoin, Catherine Souaille, Fabrice Viviani, Michel Tabart
  • Taxoids, their preparation and pharmaceutical composition containing them
    Patent number: 7074821
    Abstract: New taxoids of general formula (I), their preparation and pharmaceutical compositions containing them. In general formula (I), Ar represents an aryl radical, R represents a hydrogen atom or an acetyl, alkoxyacetyl or alkyl radical, R1 represents a benzoyl radical or a radical of formula R2—O—CO— in which R2 represents an optionally substituted alkyl radical, an alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, phenyl or heterocyclyl radical. The new products of general formula (I) have a remarkable antitumor activity.
    Type: Grant
    Filed: December 8, 1993
    Date of Patent: July 11, 2006
    Assignee: Aventis Pharma, S.A.
    Inventors: Hervé Bouchard, Jean-Dominique Bourzat, Alain Commercon
  • Chemical derivatives and their application as antitelomerase agent
    Patent number: 6995175
    Abstract: The present invention relates to cancer therapy and to novel anticancer agents having a mechanism of action which is quite specific. It also relates to novel chemical compounds as well as their therapeutic application in humans.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: February 7, 2006
    Assignee: Aventis Pharma S.A.
    Inventors: Hervé Bouchard, Augustin Hittinger
  • Pharmacological uses of azetidine derivatives
    Patent number: 6872717
    Abstract: A method of treating or preventing obesity, this method comprising administering to a patient in need of such treatment an effective amount of a compound of formula in which R, R3 and R4 are as defined in the specification.
    Type: Grant
    Filed: September 12, 2002
    Date of Patent: March 29, 2005
    Assignee: Aventis Pharma S.A.
    Inventors: Daniel Achard, Hervé Bouchard, Jean Bouquerel, Bruno Filoche, Serge Grisoni, Augustin Hittinger, Michael R. Myers
  • Acetindine derivatives, their preparation and medicaments containing them
    Patent number: 6858603
    Abstract: Disclosed are azetidine derivatives of formula: their optical isomers, their salts, their preparation and medicaments containing them.
    Type: Grant
    Filed: December 16, 2002
    Date of Patent: February 22, 2005
    Assignee: Aventis Pharma S.A.
    Inventors: Daniel Achard, Hervé Bouchard, Jean Bouquerel, Marc Capet, Serg Grisoni, Jean-Luc Malleron, Serge Mignani, Augustin Hittinger